Clincosm LogoSign in Get a demo

sglt2 inhibitors

Showing 1 - 4 of 4
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SLE, Lupus Nephritis, SGLT2 Inhibitors Trial in Mansoura (dapagliflozin, )

Active, not recruiting
  • SLE
  • +2 more
  • Mansoura, Egypt
    Urology and Nephrology Center
Feb 18, 2023

SGLT2 INHIBITORS, Lupus Nephritis, BMD Trial in Mansoura (Dapagliflozin tablet, )

Active, not recruiting
  • SGLT2 INHIBITORS
  • +2 more
  • Dapagliflozin tablet
  • placebo
  • Mansoura, Egypt
    Urology and Nephrology Center
Jan 19, 2023

Cancers Among Diabetics ,Observational Study

Enrolling by invitation
  • Cancer
  • +3 more
  • interleukin 6
  • Riyadh, N/A (Non-US), Saudi Arabia
    ministry of health , First health cluster , Riaydh
Oct 28, 2022

Chronic Hepatitis b, NAFLD, Cirrhosis Trial in Hong Kong (Empagliflozin 10 MG, Placebo pills)

Recruiting
  • Chronic Hepatitis b
  • +5 more
  • Empagliflozin 10 MG
  • Placebo pills
  • Hong Kong, Hong Kong, China, Hong Kong
    The University of Hong Kong/Queen Mary Hospital
May 31, 2022